1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Genor Biopharma Co. Ltd.

Have updates for this profile?  Please contribute data

About Deals
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2007

Location

Shanghai China

Primary Industry

Biotechnology

About

Founded in 2007 and based in Shanghai, China, Genor Biopharma Co. Ltd. is a biopharmaceutical company that focuses on the development and commercialization of therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins, and recombinant therapeutic proteins.
Current Investors
Edding Genor Group Holdings Limited, Yingke Private Equity, Temasek Holdings

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.genorbio.com
Company Stage
Merged
Total Amount Raised
Subscriber access only

Deals

Deals Type
Merger
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Edding Pharm, Genor Biopharma Co. Ltd. 13 Sep 2024
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo